In our study we differentiate between two distinct breast cancer subtypes: (1) the luminal subtype expressing the oestrogen receptor (ER) and (2) the basal-like subtype lacking ER, progesterone receptor (PgR) and HER2 expression (also known as triple-negative breast cancers or TNBCs) [12], [13]. The gene discussed is PGR; the disease is breast cancer.